Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_assertion type Assertion NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_head.
- NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_assertion wasGeneratedBy ECO_0000203 NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_provenance.
- NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_assertion wasDerivedFrom befree-2016 NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_provenance.
- NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_assertion SIO_000772 16458133 NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_provenance.
- NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_assertion evidence source_evidence_literature NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_provenance.
- NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_assertion description "[We studied the modifier effect of platelet antigen polymorphism (PlA2) on platelet inhibition by acetylsalicylic acid (ASA, i.e., aspirin), clopidogrel, or their combination in patients with coronary heart disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534504.RA8BzEZjtQ2lnFbrY5u5mo8huIf0H9OR2Top1nTTAVtpQ130_provenance.